Karyopharm Therapeutics, Inc. (KPTIQ)
0.025
-0.01
(-26.25%)
USD |
OTCM |
Nov 20, 16:00
Karyopharm Therapeutics Cash and Short Term Investments (Annual) : 63.74M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 63.74M |
| December 31, 2024 | 108.74M |
| December 31, 2023 | 192.10M |
| December 31, 2022 | 279.03M |
| December 31, 2021 | 234.96M |
| December 31, 2020 | 251.72M |
| December 31, 2019 | 263.07M |
| December 31, 2018 | 328.20M |
| Date | Value |
|---|---|
| December 31, 2017 | 146.67M |
| December 31, 2016 | 129.55M |
| December 31, 2015 | 175.63M |
| December 31, 2014 | 205.72M |
| December 31, 2013 | 155.97M |
| December 31, 2012 | 159.53M |
| December 31, 2011 | 6.512M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Heron Therapeutics, Inc. | 46.63M |
| Tonix Pharmaceuticals Holding Corp. | 207.64M |
| Minerva Neurosciences, Inc. | 82.40M |
| Corbus Pharmaceuticals Holdings, Inc. | 163.94M |
| Ocugen, Inc. | 18.57M |